Navigating Decisions in a New Treatment Era in HCC: Current Evidence, Key Trials, and Future Frontiers

In this online program based on a dynamic CCO symposium from the 2020 ASCO GI Symposium experts discuss evidence-based best practices in treating patients with HCC. Watch the on-demand Webcast and download the slides now.

Share

Program Content

Activities

First-line Therapy
Selection of First-line Therapy in Advanced, Unresectable HCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 23, 2020

Expires: January 21, 2021

Incorporating Immunotherapy
Incorporating Immune Checkpoint Inhibitors Into Treatment For Patients With HCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 23, 2020

Expires: January 21, 2021

Targeted Second-Line Therapy
Targeted Therapy Options in the Second-line Setting for Patients With Advanced HCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 23, 2020

Expires: January 21, 2021

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Eisai

Merck Sharp & Dohme Corp.